NDC 80425-0239-01 - Moxifloxacin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0239
- Requested NDC
- 80425-0239-01
- Package NDCs from labels
- 80425-0239-1, 80425-0239-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Moxifloxacin - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0239-1 | Moxifloxacin | 3 mL in 1 BOTTLE, DROPPER | SOLUTION/ DROPS | 3 | 3 | |
| 80425-0239-1 | Moxifloxacin | 1 in 1 CARTON | SOLUTION/ DROPS | 1 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0239 | MOXIFLOXACIN SOLUTION/ DROPS [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 3 | Current NDC, 2 package rows | 20250102_f19fa89e-9f5d-4eed-e053-2995a90ac3ce.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0239-1 | ML - Milliliter | 80425-0239 | b22cdef2-08d4-45f9-aadc-dfc84bca01b7 | 1 | 2023-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Moxifloxacin | MOXIFLOXACIN | Advanced Rx Pharmacy of Tennessee, LLC | 143075b4-24d4-08a1-e063-6394a90a8a6e | 2024-03-21 | Warnings, Adverse reactions | 403818 B8956S8609 |
| MOXIFLOXACIN | MOXIFLOXACIN | Proficient Rx LP | c38e051f-5765-4066-9953-2d0832481b1e | 2024-01-01 | Warnings, Adverse reactions | 403818 |
| Moxifloxacin Ophthalmic Solution | MOXIFLOXACIN OPHTHALMIC | Fosun Pharma USA Inc. | 9eae534a-9253-4a45-9ab7-2543626f49e6 | 2023-12-17 | Warnings, Adverse reactions | 403818 |
| Moxifloxacin ophthalmic solution | MOXIFLOXACIN OPHTHALMIC | A-S Medication Solutions | e33b3315-54f6-47ce-8a4f-3b79be408540 | 2023-12-15 | Warnings, Adverse reactions | 403818 |
| Moxifloxacin Ophthalmic | MOXIFLOXACIN OPHTHALMIC | A-S Medication Solutions | c76f7d78-1e52-4557-a43b-cfc8e5842c80 | 2023-10-31 | Warnings, Adverse reactions | 403818 |
| Moxifloxacin Hydrochloride | MOXIFLOXACIN HYDROCHLORIDE | Upsher-Smith Laboratories, LLC | 5a5d72e2-aa39-4ead-af72-d3cabe72a5b7 | 2023-05-30 | Warnings, Adverse reactions | 403818 |
| Moxifloxacin | MOXIFLOXACIN | A-S Medication Solutions | 4dee7a26-25e2-4ce9-8fd2-e8c3ac6ef5ff | 2023-04-19 | Warnings, Adverse reactions | 403818 |
| MOXIFLOXACIN | MOXIFLOXACIN | NorthStar Rx LLC | cdc0b0eb-5f56-45c7-b9fd-364752a95ff1 | 2022-12-28 | Warnings, Adverse reactions | 403818 |
| Moxifloxacin Ophthalmic Solution | MOXIFLOXACIN HYDROCHLORIDE | Sandoz Inc | fc88791b-24da-48a4-85f5-93a8af3d0b51 | 2020-06-15 | Warnings, Adverse reactions | 403818 |
| Moxifloxacin Ophthalmic Solution | MOXIFLOXACIN OPHTHALMIC | Gland Pharma Limited | 95773bca-0791-4bfe-955a-4d2fa4561e01 | 2020-06-10 | Warnings, Adverse reactions | 403818 |
| Moxifloxacin Hydrochloride Tablets, 400 mg | MOXIFLOXACIN HYDROCHLORIDE TABLETS, 400 MG | Novadoz Pharmaceuticals LLC | 04e0936f-2248-48e4-8031-ac6ccc2df294 | 2019-04-20 | Boxed warning, Warnings, Adverse reactions | B8956S8609 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.